60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.400
+0.010 (0.72%)
Jun 10, 2026, 9:55 AM EDT - Market open
SXTP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | - | - | - | 0.26 | 0.12 |
Short-Term Investments | - | 1.24 | 1.73 | - | - | - |
Cash & Short-Term Investments | - | 1.24 | 1.73 | 2.14 | 0.26 | 0.12 |
Cash Growth | - | -28.22% | -19.32% | 708.90% | 129.52% | -39.80% |
Accounts Receivable | - | - | - | 0.23 | 0.05 | 0.15 |
Inventory | - | - | - | 0.47 | 0.52 | 0.69 |
Other Current Assets | - | - | - | 4.4 | 0.27 | 0.23 |
Total Current Assets | - | 1.24 | 1.73 | 7.24 | 1.1 | 1.18 |
Net Property, Plant & Equipment | - | - | 0.15 | 0.07 | 0.03 | 0.11 |
Other Intangible Assets | - | - | 0.16 | 0.23 | 0.16 | 0.11 |
Other Long-Term Assets | - | - | 0.07 | 0.24 | - | - |
Total Assets | 6.76 | 5.37 | 5.76 | 7.78 | 1.3 | 1.39 |
Accounts Payable | - | - | - | 0.51 | 0.76 | 0.59 |
Short-Term Debt | - | - | 0.01 | 0.01 | 21.33 | - |
Current Portion of Leases | - | - | - | 0.01 | 0.01 | 0.05 |
Other Current Liabilities | - | - | - | 2.31 | 1.82 | - |
Total Current Liabilities | - | - | 0.01 | 2.84 | 23.92 | 0.64 |
Long-Term Debt | - | - | 0.15 | 0.15 | 1.27 | 18.74 |
Long-Term Leases | - | - | - | - | - | 0.01 |
Other Long-Term Liabilities | - | - | - | - | 0.26 | 0.15 |
Total Long-Term Liabilities | - | - | 0.15 | 0.15 | 1.53 | 18.91 |
Total Liabilities | - | - | 0.16 | 2.99 | 25.45 | 19.55 |
Preferred Stock | 9.57 | 9.57 | 9.57 | 9.86 | - | - |
Common Stock | - | - | - | 0 | 0 | - |
Additional Paid-in Capital | 45.1 | 41.65 | 34.86 | 27.46 | 5.16 | - |
Accumulated Other Comprehensive Income | 0.15 | 0.14 | 0.14 | 0.14 | 0.07 | 0.08 |
Retained Earnings | -49.98 | -47.89 | -40.53 | -32.58 | -28.82 | -22.63 |
Total Common Shareholders' Equity | 4.83 | 3.46 | 4.04 | 4.87 | -23.58 | -12.6 |
Minority Interest | -0.08 | -0.08 | -0.08 | -0.07 | -0.57 | -0.58 |
Shareholders' Equity | 4.74 | 3.38 | 3.95 | 4.8 | -24.15 | -18.15 |
Total Liabilities & Equity | 6.76 | 5.37 | 5.76 | 7.78 | 1.3 | 1.39 |
Total Debt | - | 0 | 0.16 | 0.17 | 22.61 | 18.8 |
Net Cash (Debt) | - | 1.24 | 1.57 | 1.97 | -22.35 | -18.69 |
Net Cash Growth | - | -21.10% | -20.17% | - | - | - |
Net Cash Per Share | - | 1.85 | 13.84 | 118.82 | -799.13 | -668.28 |
Book Value | 4.83 | 3.46 | 4.04 | 4.87 | -23.58 | -12.6 |
Book Value Per Share | 4.74 | 5.17 | 35.50 | 293.76 | -843.05 | -450.51 |
Tangible Book Value | 4.83 | 3.46 | 3.88 | 4.64 | -23.74 | -12.71 |
Tangible Book Value Per Share | 4.74 | 5.17 | 34.12 | 280.05 | -848.92 | -454.41 |